JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB218123

Anti-Bcl-2 (phospho S70) antibody [EPR21162]

Be the first to review this product! Submit a review

|

(17 Publications)

Rabbit Recombinant Monoclonal Bcl-2 phospho S70 antibody. Suitable for IP, Dot, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Synthetic peptide samples. Cited in 17 publications.

View Alternative Names

Apoptosis regulator Bcl-2, BCL2

6 Images
Flow Cytometry (Intracellular) - Anti-Bcl-2 (phospho S70) antibody [EPR21162] (AB218123)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-Bcl-2 (phospho S70) antibody [EPR21162] (AB218123)

Intracellular flow cytometric analysis of 80% methanol-fixed, 0.1% Tween-20 permeabilized HeLa (human epithelial cell line from cervix adenocarcinoma) cell line labeling Bcl-2 (phospho S70)with ab218123 at 1/500 dilution (right panel) compared with a Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (left panel). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) at 1/2000 dilution was used as the secondary antibody.

Cells were pretreated with 20 μg/ml RNase A for 30 minutes to eliminate the non-specific binding between RNA and propidium iodide (PI).

Bcl-2 (phospho S70) is highly expressed in mitotic cells (PMID : 10567572).

Immunocytochemistry/ Immunofluorescence - Anti-Bcl-2 (phospho S70) antibody [EPR21162] (AB218123)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-Bcl-2 (phospho S70) antibody [EPR21162] (AB218123)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (human epithelial cell line from cervix adenocarcinoma) cells labeling Bcl-2 (phospho S70) with ab218123 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/100 dilution (green). Confocal image showing positive staining in HeLa cells in M phase. The nuclear counter stain is DAPI (blue).

Tubulin is detected with Anti-alpha Tubulin mouse MAb (ab195889) at 1/200 dilution (red). Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) at 1/1000 dilution.

Flow Cytometry (Intracellular) - Anti-Bcl-2 (phospho S70) antibody [EPR21162] (AB218123)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-Bcl-2 (phospho S70) antibody [EPR21162] (AB218123)

Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed,90% methanol permeabilized Jurkat (human T cell leukemia T lymphocyte) treated with 1 μM paclitaxel for 24h (Right) / Untreated control (Left) cell line labeling Bcl-2 (phospho S70)with ab218123 at 1/500 dilution. Goat Anti-Rabbit IgG H&L (Alexa Fluor®488) (ab150077) at 1/2000 dilution was used as the secondary antibody.

Square gate shows Bcl-2 (phospho S70) positive signal. The expression profile is consistent with what has been described in the literature (PMID : 10097113)

Immunoprecipitation - Anti-Bcl-2 (phospho S70) antibody [EPR21162] (AB218123)
  • IP

Supplier Data

Immunoprecipitation - Anti-Bcl-2 (phospho S70) antibody [EPR21162] (AB218123)

Bcl-2 (phospho S70) was immunoprecipitated from 0.35 mg of Jurkat (human T cell leukemia cells from peripheral blood) treated with 1 μM paclitaxel for 24 hours whole cell lysate with ab218123 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab218123 at 0.5 μg/ml. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution.

Lane 1 : Jurkat treated with 1 μM paclitaxel for 24 hours whole cell lysate 10 μg (Input).

Lane 2 : ab218123 IP in Jurkat treated with 1 μM paclitaxel for 24 hours whole cell lysate.

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab218123 in Jurkat treated with 1 μM paclitaxel for 24 hours whole cell lysate.

Blocking/ Dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 15 seconds.

All lanes:

Immunoprecipitation - Anti-Bcl-2 (phospho S70) antibody [EPR21162] (ab218123)

Predicted band size: 26 kDa

false

Western blot - Anti-Bcl-2 (phospho S70) antibody [EPR21162] (AB218123)
  • WB

Supplier Data

Western blot - Anti-Bcl-2 (phospho S70) antibody [EPR21162] (AB218123)

Blocking/Dilution buffer and concentration : 2% BSA/TBST

The expression profile observed is consistent with what has been described in the literature (PMID : 10097113).

All lanes:

Western blot - Anti-Bcl-2 (phospho S70) antibody [EPR21162] (ab218123) at 1/5000 dilution

Lane 1:

Untreated Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg

Lane 2:

Jurkat treated with 1 μM paclitaxel for 24 hours whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 26 kDa

false

Exposure time: 32s

Dot Blot - Anti-Bcl-2 (phospho S70) antibody [EPR21162] (AB218123)
  • Dot

Supplier Data

Dot Blot - Anti-Bcl-2 (phospho S70) antibody [EPR21162] (AB218123)

Dot blot analysis of Bcl-2 (phospho S70) labeled with ab218123 at 1/1000 dilution.

Lane 1 : Bcl-2 (phospho S70) peptide.
Lane 2 : Bcl-2 non-phospho peptide.

Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100,000 dilution was used as secondary antibody.

Blocking and dilution buffer : 2% BSA/TBST.

Exposure time : 58 seconds.

  • Carrier free

    Anti-Bcl-2 (phospho S70) antibody [EPR21162] - BSA and Azide free

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Bcl-2 (phospho S70) antibody [EPR21162]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR21162

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, ICC/IF, IP, Flow Cyt (Intra), Dot

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "Dot" : {"fullname" : "Dot Blot", "shortname":"Dot"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "Dot-species-checked": "guaranteed", "Dot-species-dilution-info": "", "Dot-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/1000", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/500", "FlowCytIntra-species-notes": "<p></p>" }, "Synthetic peptide": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "Dot-species-checked": "testedAndGuaranteed", "Dot-species-dilution-info": "1/1000", "Dot-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Bcl-2 also known as B-cell lymphoma 2 is an important protein involved in the regulation of apoptosis. It mechanically functions by inhibiting cell death and is a member of the Bcl-2 family of proteins. Bcl-2 has a molecular weight of approximately 26 kDa. It is expressed mainly in fetal and adult tissues including the immune system and is notably present in hematopoietic stem cells and various cell lines derived from lymphoid tissues. In laboratory practices scientists often assess Bcl-2 expression levels through techniques like western blotting using antibodies such as 10c4 for detection.
Biological function summary

The role of Bcl-2 extends to maintaining cell survival and balancing apoptotic signals. It functions as an anti-apoptotic molecule within the cell primarily involved in forming complexes with pro-apoptotic members of the Bcl-2 family like Bax and Bak. These interactions prevent mitochondrial membrane permeabilization which is an important step in apoptotic signal transduction. As an important regulator of apoptosis Bcl-2 helps in cellular homeostasis and appropriate immune responses under physiological conditions.

Pathways

Bcl-2 plays a critical role in the intrinsic or mitochondrial pathway of apoptosis. Within this pathway Bcl-2 interacts with other proteins such as cytochrome c and APAF-1 to inhibit apoptosis. This pathway involves a network of Bcl-2 family proteins where Bcl-2's anti-apoptotic role counteracts the pro-apoptotic activity of proteins like Bax. These interactions help fine-tune the apoptotic response to various internal stimuli maintaining cellular integrity and function.

The dysregulation of Bcl-2 expression has been implicated in cancer and autoimmune diseases. Overexpression of Bcl-2 is associated with several types of cancer including lymphomas and breast cancer where its anti-apoptotic property leads to tumor cell survival and resistance to chemotherapy. Bcl-2 also connects to disorders such as autoimmune diseases due to its regulation of cell survival with proteins like Bim playing an opposite role in promoting apoptosis. Understanding Bcl-2's functionality within these contexts is essential for developing targeted therapies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells (PubMed : 1508712, PubMed : 8183370). Regulates cell death by controlling the mitochondrial membrane permeability (PubMed : 11368354). Appears to function in a feedback loop system with caspases (PubMed : 11368354). Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (PubMed : 11368354). Also acts as an inhibitor of autophagy : interacts with BECN1 and AMBRA1 during non-starvation conditions and inhibits their autophagy function (PubMed : 18570871, PubMed : 20889974, PubMed : 21358617). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (PubMed : 17418785).
See full target information BCL2 pS70

Publications (17)

Recent publications for all applications. Explore the full list and refine your search

Aging cell 23:e14124 PubMed38380563

2024

N-homocysteinylation of DJ-1 promotes neurodegeneration in Parkinson's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Tao Guo,Lingyan Zhou,Min Xiong,Jing Xiong,Juan Huang,Yiming Li,Guoxin Zhang,Guiqin Chen,Zhi-Hao Wang,Tingting Xiao,Dan Hu,Anyu Bao,Zhentao Zhang

Scientific reports 13:5363 PubMed37005451

2023

Long noncoding RNA SNHG6 silencing sensitized esophageal cancer cells to 5-FU via EZH2/STAT pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Ran Tan,Jia Liu,Jiang Wang,Wei Zhang,Meng He,Yueli Zhang

PLoS pathogens 19:e1011201 PubMed36888569

2023

Autophagy is induced by swine acute diarrhea syndrome coronavirus through the cellular IRE1-JNK-Beclin 1 signaling pathway after an interaction of viral membrane-associated papain-like protease and GRP78.

Applications

Unspecified application

Species

Unspecified reactive species

Da Shi,Ling Zhou,Hongyan Shi,Jiyu Zhang,Jialin Zhang,Liaoyuan Zhang,Dakai Liu,Tingshuai Feng,Miaomiao Zeng,Jianfei Chen,Xin Zhang,Mei Xue,Zhaoyang Jing,Jianbo Liu,Zhaoyang Ji,Haojie He,Longjun Guo,Yang Wu,Jingyun Ma,Li Feng

Journal of biochemical and molecular toxicology 37:e23247 PubMed36654514

2023

MiR-526b targets lncRNA SLC16A1-AS1 to suppress cell proliferation in triple-negative breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Xingjuan Zhao,Lei Fu,Liqin Zhai,Xuan Yang,Runfang Gao

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 34:211-220 PubMed36511604

2022

Raw Lacquer Extract from Toxicodendron vernicifluum in Combination with ONC201 Enhances the Inhibitory Effects on Colorectal Cancer Cell Activity.

Applications

Unspecified application

Species

Unspecified reactive species

Zhezhu Jin,Yongjun Jin

Translational research : the journal of laboratory and clinical medicine 253:31-40 PubMed36243313

2022

PFKFB3 mediates tubular cell death in cisplatin nephrotoxicity by activating CDK4.

Applications

Unspecified application

Species

Unspecified reactive species

Lu Wen,Qingqing Wei,Man J Livingston,Guie Dong,Siyao Li,Xiaoru Hu,Ying Li,Yuqing Huo,Zheng Dong

Bioengineered 13:14125-14137 PubMed35730472

2022

SOCS5 contributes to temozolomide resistance in glioblastoma by regulating Bcl-2-mediated autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Jie Yu,Lin Han,Feng Yang,Mingliang Zhao,Hong Zhou,Linwang Hu

Bioengineered 13:9411-9424 PubMed35412947

2022

Long non-coding RNA-PCGEM1 contributes to prostate cancer progression by sponging microRNA miR-129-5p to enhance chromatin licensing and DNA replication factor 1 expression.

Applications

Unspecified application

Species

Unspecified reactive species

Qiao Fu,Fangfang Wang,Jun Yang,Wei Sun,Zhi Hu,Lv Xu,Hao Chu,Xiao Wang,Wei Zhang

Cancer cell international 22:150 PubMed35410346

2022

RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Rui Shi,Zirong Liu

Bioengineered 13:1359-1376 PubMed35012438

2022

Long non-coding RNA p53 upregulated regulator of p53 levels (PURPL) promotes the development of gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Zhonghua Cheng,Jing Hong,Nan Tang,Fenghua Liu,Shuo Gu,Zhen Feng
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com